In this section
@article{Nuriev:2019:10.12688/f1000research.20061.1,
author = {Nuriev, R and Johansson, C},
doi = {10.12688/f1000research.20061.1},
journal = {F1000Res},
title = {Chemokine regulation of inflammation during respiratory syncytial virus infection.},
url = {http://dx.doi.org/10.12688/f1000research.20061.1},
volume = {8},
year = {2019}
}
TY - JOUR
AB - Respiratory syncytial virus (RSV) can cause severe lower respiratory tract infections especially in infants, immunocompromised individuals and the elderly and is the most common cause of infant hospitalisation in the developed world. The immune responses against RSV are crucial for viral control and clearance but, if dysregulated, can also result in immunopathology and impaired gas exchange. Lung immunity to RSV and other respiratory viruses begins with the recruitment of immune cells from the bloodstream into the lungs. This inflammatory process is controlled largely by chemokines, which are small proteins that are produced in response to innate immune detection of the virus or the infection process. These chemokines serve as chemoattractants for granulocytes, monocytes, lymphocytes and other leukocytes. In this review, we highlight recent advances in the field of RSV infection and disease, focusing on how chemokines regulate virus-induced inflammation.
AU - Nuriev,R
AU - Johansson,C
DO - 10.12688/f1000research.20061.1
PY - 2019///
TI - Chemokine regulation of inflammation during respiratory syncytial virus infection.
T2 - F1000Res
UR - http://dx.doi.org/10.12688/f1000research.20061.1
UR - https://www.ncbi.nlm.nih.gov/pubmed/31723414
UR - http://hdl.handle.net/10044/1/76194
VL - 8
ER -
